Ahlstrom completes the acquisition of Munktell
October 25, 2012
Ahlstrom, a global high-performance materials company, has completed the acquisition of Munktell Filter AB. The company produces filtration materials mainly for life science and laboratory applications. Under the agreement, Ahlstrom acquired 100 percent of the shares in Munktell Filter AB, as well as its holdings in Munktell & Filtrak GmbH, Filtres Fioroni SA and Munktell [...]
October 25, 2012
Hilden, Germany,- QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) and Bayer HealthCare today announced a collaboration agreement for the development and commercialization of companion diagnostics paired with novel Bayer HealthCare drugs, initially to enhance the treatment of various solid tumors. Companion diagnostics are tests that unlock molecular information from each patient's tumor genome to guide [...]
October 25, 2012
SAN FRANCISCO – –This week’s Roddenberry International Symposium on Cellular Reprogramming in San Francisco will be Drs. Shinya Yamanaka and John Gurdon first public appearance together since being named 2012 Nobel Laureates, according to the ISSCR’s (International Society for Stem Cell Research) website. The Roddenberry International Symposium is a collaborative effort between the ISSCR and [...]
October 25, 2012
REDWOOD CITY, Calif. —— Verinata Health Inc., a privately-held company dedicated to maternal and fetal health, today announced that it has commenced an action against Ariosa Diagnostics, Inc. (Ariosa) and Laboratory Corporation of America Holdings (LabCorp) in federal court in the Northern District of California. The action asserts that Ariosa and LabCorp infringe U. S. [...]
Techne Corporation Declares Dividend And Announces An Increase In Its Share Repurchase Program
October 25, 2012
Minneapolis -- Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.30 per share for the quarter ended September 30, 2012. The quarterly dividend will be payable November 19, 2012 to all common shareholders of record on November 5, 2012. Future cash dividends will be considered by the [...]
Pacific Biosciences of California, Inc. Announces Third Quarter 2012 Financial Results
October 25, 2012
MENLO PARK, Calif., -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced financial results for the third quarter ended September 30, 2012. During the third quarter of 2012, the Company recognized revenue from SMRT® Cell and reagent consumables, instrument service contracts and grants. Revenue for the third quarter of 2012 totaled $2.8 million compared to [...]
October 25, 2012
Chicago, IL and Burlington, MA. – Today, KineMatik, creator of the eNovator Suite of R&D software products and the leading provider of Electronic Laboratory Notebooks (ELNs), and Scilligence, the leading provider of next-generation, cross-platform, mobile cheminformatics, and bioinformatics software tools for life science organizations, announced a strategic alliance and reseller agreement. Since 1999 KineMatik has [...]
Wayne Brinster Joins WHEATON® as President
October 25, 2012
Millville, NJ,– WHEATON, the company that designs and delivers innovative solutions for the laboratory research, diagnostic packaging and specialty pharmaceuticals industries, announced the appointment of Wayne Brinster to the role of president, succeeding Stephen R, Drozdow, who remains as chief executive officer. Mr. Brinster brings to the position a familiar, science-driven focus while sharing Mr. [...]
OmniDriver Spectroscopy Platform Updated
October 25, 2012
Ocean Optics has released an update to its OmniDriver Spectroscopy Development Platform. The platform-neutral Java based OmniDriver Version 2.20 provides a simple interface for programming of USB spectrometers, accessories and devices in optical sensing systems, and is available with an optional set of spectral processing math algorithms. New features have improved the platform’s high-speed data [...]
October 25, 2012
Paris, France, - Cellectis (Alternext: ALCLS), the genome engineering specialist, announces that it has signed two exclusive license agreements with the Iowa State University that grant Cellectis the worldwide right to use inventions related to TAL effector-nucleases (TALENsTM) and monomeric TALENsTM . These two exclusive licenses granted to Cellectis cover all uses of the TAL [...]

